Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana

被引:189
作者
Schierenbeck, Thomas [1 ]
Riemann, Dieter [1 ]
Berger, Mathias [1 ]
Hornyak, Magdolna [1 ,2 ]
机构
[1] Univ Freiburg, Med Ctr, Dept Psychiat & Psychotherapy, D-79104 Freiburg, Germany
[2] Univ Freiburg, Med Ctr, Interdisciplinary Pain Ctr, D-79104 Freiburg, Germany
关键词
Cocaine; Ecstasy; Cannabis; Marijuana; Tetrahydrocannabinol; Recreational drugs; Sleep; Withdrawal;
D O I
10.1016/j.smrv.2007.12.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The illicit recreational drugs cocaine, ecstasy and marijuana have pronounced effects upon sleep. Administration of cocaine increases wakefulness and suppresses REM sleep. Acute cocaine withdrawal is often associated with sleep disturbances and unpleasant dreams. Studies have revealed that polysomnographically assessed sleep parameters deteriorate even further during sustained abstinence, although patients report that sleep quality remains unchanged or improves. This deterioration of objective sleep measures is associated with a worsening in sleep-related cognitive performance. Like cocaine, 3,4-methytene-dioxymethamphetamine (MDMA; "ecstasy") is a substance with arousing properties. Heavy MDMA consumption is often associated with persistent sleep disturbances. Polysomnography (PSG) studies have demonstrated altered sleep architecture in abstinent heavy MDMA users. Smoked marijuana and oral Delta-9-tetrahydrocannabinol (THC) reduce REM sleep. Moreover, acute administration of cannabis appears to facilitate falling asleep and to increase Stage 4 sleep. Difficulty sleeping and strange dreams are among the most consistently reported symptoms of acute and subacute cannabis withdrawal. Longer sleep onset latency, reduced stow wave sleep and a REM rebound can be observed. Prospective studies are needed in order to verify whether sleep disturbances during cocaine and cannabis withdrawal predict treatment outcome. (C) 2008 Elsevier Ltd. AR rights reserved.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 92 条
  • [31] GILLIN JC, 1994, BIOL PSYCHIAT, V35, P843
  • [32] Gillin JC, 1972, J SLEEP RES, V1, P44
  • [33] SLEEP EEG EFFECTS OF 3,4-METHYLENEDIOXYETHAMPHETAMINE (MDE EVE) IN HEALTHY-VOLUNTEERS
    GOUZOULIS, E
    STEIGER, A
    ENSSLIN, M
    KOVAR, A
    HERMLE, L
    [J]. BIOLOGICAL PSYCHIATRY, 1992, 32 (12) : 1108 - 1117
  • [34] Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank, E
    Daumann, J
    [J]. ADDICTION, 2006, 101 (03) : 348 - 361
  • [35] Circadian and wake-dependent modulation of fastest and slowest reaction times during the psychomotor vigilance task
    Graw, P
    Kräuchi, K
    Knoblauch, V
    Wirz-Justice, A
    Cajochen, C
    [J]. PHYSIOLOGY & BEHAVIOR, 2004, 80 (05) : 695 - 701
  • [36] The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
    Green, AR
    Mechan, AO
    Elliott, JM
    O'Shea, E
    Colado, MI
    [J]. PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 463 - 508
  • [37] Pharmacokinetics and pharmacodynamics of cannabinoids
    Grotenhermen, F
    [J]. CLINICAL PHARMACOKINETICS, 2003, 42 (04) : 327 - 360
  • [38] A LONGITUDINAL-STUDY OF MARIJUANA EFFECTS
    HALIKAS, JA
    WELLER, RA
    MORSE, CL
    HOFFMANN, RG
    [J]. INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1985, 20 (05): : 701 - 711
  • [39] Marijuana withdrawal in humans: Effects of oral THC or divalproex
    Haney, M
    Hart, CL
    Vosburg, SK
    Nasser, J
    Bennett, A
    Zubaran, C
    Foltin, RW
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (01) : 158 - 170
  • [40] Abstinence symptoms following oral THC administration to humans
    Haney, M
    Ward, AS
    Comer, SD
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (04) : 385 - 394